# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Matthew O'Brien downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Overweight to Neutral and lowers...
The Benzinga Stock Whisper highlights five stocks that caught an increased amount of attention from readers and investors durin...
--TMINI System Complements Company's Flagship ROSA® Robotics Portfolio Featuring Applications for Knee, Hip and Shoulder Ar...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a limited distribution ag...
Barclays analyst Matt Miksic maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Underweight and lowers the price target from...